Food-Drug Interactions Could be Impactful for Some Lung Cancer Patients According to New Study in JNCCN

New study on diet-medication interactions warns that targeted treatment alectinib becomes less effective when taken with a low-fat breakfast. PLYMOUTH MEETING, Pa., June 12, 2023 /PRNewswire/ — New research in the June 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that when alectinib—a safe and effective small molecule kinase inhibitor used to … Read more